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Abstract
Background: A large number of natural antisense transcripts have been identified in human and
mouse genomes. Study of their potential functions clearly requires cost-efficient method for
expression analysis.
Results: Here we show that Affymetrix Exon arrays, which were designed to detect conventional
transcripts in the sense orientation, can be used to monitor antisense expression across all exonic
loci in mammalian genomes. Through modification of the cDNA synthesis protocol, we labeled
single-strand cDNA in the reverse orientation as in the standard protocol, thus enabling the
detection of antisense transcripts using the same array. Applying this technique to human Jurkat
cells, we identified antisense transcription at 2,088 exonic loci of 1,516 UniGene clusters. Many of
these antisense transcripts were not observed previously and some were validated by orientation-
specific RT-PCR.
Conclusion: Our results suggest that with a modified protocol Affymetrix human, mouse and rat
Exon arrays can be used as a routine method for genome-wide analysis of antisense transcription
in these genomes.
Background
Genome-wide analyses of mRNA and cDNA sequences
have revealed large-scale antisense transcription in vari-
ous animal and plant species. Based on analysis of mouse
full length cDNA generated by FANTOM2 consortium,
Okazaki et al. identified 2,481 pairs of overlapping sense/
antisense transcripts [1]. An updated analysis using
FANTOM3 cDNAs and mouse cDNA at GenBank showed
that there are 4,520 transcription units forming sense and
antisense pairs on exons [2]. For human, Yelin et al. [3]
and Chen et al. [4] reported 2,667 and 2,940 pairs, respec-
tively. The prevalence of natural antisense transcripts
(NATs) is also supported by data derived by sequence tag-
based technologies such as serial analysis of gene expres-
sion (SAGE) [5-7] and massively parallel signature
sequencing (MPSS) [8].
Microarray-based studies also confirmed the prevalence of
antisense transcripts. Using strand-specific oligonucle-
otide probes Yelin et al. studied the expression of both
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strands of 264 genomic loci in 19 human cell lines and
detected antisense transcription in 112 (42.5%) of these
loci [3]. Kiyosawa et al. studied the expression of 1,947
mouse NAT pairs in five types of cells and tissues using
custom-made oligonucleotide arrays that distinguish the
expression of sense versus antisense transcripts [9]. A
research group at Affymetrix [10,11] used a novel direct
RNA end-labeling method to detect the orientation of
transcripts with a tiling array integrating chromosome 21
and 22 at a resolution of every probe per 35 base pair
(bp). The analysis was later extended to 10 chromosomes
at 5 bp resolution [12]. The data strongly support the
observation that transcripts encoded on both DNA
strands often results in complementary mRNAs. By focus-
ing on 1% of human genome, the ENCODE project gen-
erated tiling array data suggesting that the majority of the
bases of human genome is transcribed [13].
To investigate potential functions of the large number of
NATs clearly requires cost-efficient technology for
genome-wide expression analysis in a strand-specific
manner. Because of the lack of technology for routine
analysis, an interesting study took advantage of incor-
rectly orientated probes in commercial arrays [14]. About
25% of the probes on the first version of Affymetrix
mouse U74A and U74B arrays were designed and manu-
factured in the wrong orientation [15]. Werner et al. used
these faulty arrays to detect the expression of antisense
transcripts in mouse brain and kidney [14]. Their result
show that the antisense transcription is tissue specific and
that the sensitivity of commercial arrays is sufficient to
assess NATs in total RNAs.
In this proof-of-concept study, we demonstrate the appli-
cability of Affymetrix Exon array to detect antisense tran-
scripts at the whole-genome level. By modifying the
standard cDNA synthesis and labeling process, we could
labels single-strand cDNA in the reverse direction as com-
pared to the standard protocol. Thus we can use Affyme-
trix Exon array to detect transcripts from antisense strands
at over 1 million exonic loci across the human genome.
Unlike previous expression arrays that target the 3' end of
annotated genes, the Affymetrix Human Genome Exon
array includes probes for all known and predicted exons.
Most exons are represented by a probe-set consisting of 3
to 4 probes of 25 bp. For convenience, a 25 bp probe will
be referred to as a "feature" and a probe-set will be called
"probe" in the rest of the paper. We present a protocol that
allows the independent labeling of sense and antisense
strand of an RNA sample in combination with exon arrays
will bring routine examinations of the antisense transcrip-
tome within reach.
Results
The Affymetrix Exon array is an inexpensive high-density
oligonucleotide microarray that has two unique features:
(1) it includes probes for all known and predicted exons,
and (2) its signals are strand-specific because of the gener-
ation and labeling of single-stranded DNA targets. Exon
arrays are currently available for human, mouse, and rat.
In the standard protocol [16], an initial cycle of reverse
transcription (RT) converts RNA into cDNA using random
primers linked with the T7 promoter. This is followed by
second-strand cDNA synthesis. The double-stranded
cDNA is then used as a template for in vitro transcription
(IVT) with T7 RNA Polymerase, which produces many
copies of cRNAs that are reverse complementary to origi-
nal RNA molecules. In the second cycle of cDNA synthe-
sis, random primers are used to reverse transcribe the
cRNA to obtain single-stranded DNA. The DNA is then
fragmented and labeled in preparation for hybridization.
After two RT cycles, the final single-strand DNA product is
in the same orientation as original RNA. Based on anno-
tation databases, the probes have been pre-manufactured
to be reverse complementary to RNA sequences, so that
the labeled product could hybridize with them.
We have tested a modified protocol called Antisense Tran-
scriptome analysis using Exon array (ATE). Compared
with the standard protocol outline above, ATE skips the
first cycle cDNA synthesis and the IVT process. The ATE
protocol starts directly from the second cycle cDNA syn-
thesis in the standard protocol, where RNA sample is used
as a template to synthesize single-strand cDNA through
RT with random primers. The cDNA is then fragmented
and labeled as recommended. Since only one cycle of RT
is involved, the labeled cDNA fragments are reverse com-
plementary to original RNA molecule, in contrary to the
standard protocol. When hybridized to Exon arrays,
cDNA derived from annotated genes can no longer
hybridize to the probes since they are in the same orienta-
tion. Instead, if there is any transcript from the opposite
DNA strand of the same genomic loci, they will give rise
to cDNA sequences reverse complementary to the probes,
thereby producing signals. Therefore, hybridization sig-
nals will represent antisense transcripts, instead of the
intended sense transcript.
To test the ATE protocol, total RNA of Jurkat cells was used
for both sense and antisense analysis. After removal of
ribosomal RNA (rRNA) from 100 μg total RNA, we
obtained 13.65 μg mRNA-enriched RNA. Sense strand
expression profiling was performed according to standard
protocol using 250 ng of this RNA. A larger amount (12
μg) was used to study the antisense gene expression
according to our ATE protocol (see Methods for details).
This will compensate for the skipped IVT amplification
step and ensure sufficient yield of labeled targets. In theBMC Genomics 2008, 9:27 http://www.biomedcentral.com/1471-2164/9/27
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antisense array, we obtained 6.4 μg fragmented, labeled
cDNA, of which 6 μg was used for hybridization.
The Affymetrix Expression Console software were used to
normalize CEL files using the quantile normalization
method and then summarize data at both the exon level
and gene level by using the Robust Multichip Analysis
(RMA) algorithm [17]. For comparison, CEL files of the
73 Exon array were downloaded from Affymetrix website,
normalized and analyzed together. These 73 arrays repre-
sent 11 types of normal tissues and some colon tumor
samples. Examination of quality control metrics showed
that both sense and antisense array data were of high qual-
ity.
The hybridization-control probes produced signals at
compatible levels in both arrays, although signals in anti-
sense array were higher (Fig. 1). Independent of the
expression signal, a detection P value was derived for each
probe by using the DABG (Detected Above BackGround)
algorithm to indicate whether the signal is significantly
higher than 1000 negative control probes with similar GC
content. In the sense array, 41.4% of 1.38 million probes
are called "present" with a detection P value less than or
equal to 0.01. The percentage of "present" probes in the
antisense array is much smaller (13.4%). Unlike previous
Affymetrix GeneChip arrays, the Exon array lacks mis-
match probes to serve as probe-specific negative controls.
This makes the "present" calls less reliable and thus we
could not assume that 13.4% of exonic loci give rise to
antisense transcripts. As discussed in the following sec-
tions, other measures should be used to complement
detection calls to rule out non-specific signals.
Since fewer genes were expressed in the antisense array,
quartile normalization led to larger signals. The hybridi-
zation control probes in the antisense array produced sig-
nals that were on average 1.58 times larger than these in
the sense array. In order to make signals compatible, we
linearly scaled down the antisense signal by this factor.
Signals of control probes indicate that antisense array is 
strand-specific
The Affymetrix exon array includes a set of 1195 positive
control probes representing exons of 100 housekeeping
genes that are usually highly expressed in most tissues.
The array also includes 2904 negative-control probes.
They are selected from the intronic regions of these genes
that are not supposed to be expressed. Based on the sam-
ple dataset provided by Affymetrix covering 11 types of
normal tissues, we filtered out some positive controls that
fail to produce comparably high expression scores across
all samples and some negative controls produce high
scores in some or all of the samples. The numbers of pos-
itive and negative control probes were reduced to 915 and
942, respectively.
Figure 1 shows the expression of these probes in both
sense and antisense arrays. The signals from negative con-
trol probes in both arrays are at the same low levels. On
the other hand, the 915 positive control probes gave sig-
nificantly higher signals in the sense array than in the anti-
sense array. Also, within the sense array, positive control
probes produce signals that are about two orders of mag-
nitude higher than negative control probes. In the anti-
sense array this strong induction is diminished as both
positive and negative controls produce very low signals.
This is expected since the 915 positive control probes are
designed to detect high signals only on the annotated
strand. Antisense transcription is not likely to occur on
these loci of housekeeping genes because of their high
expression level and fundamental importance for basic
cellular function. The low signals of positive control
probes indicate that our ATE approach does not detect
transcripts on the sense strand, including housekeeping
genes expressed at high levels.
Scatter plot of the signals of control probes in sense (x-axis)  and antisense (y-axis) arrays Figure 1
Scatter plot of the signals of control probes in sense 
(x-axis) and antisense (y-axis) arrays. The hybridization 
control probes (open squares) are highly expressed in both 
arrays. The signals of introns of housekeeping genes (blue 
dots) are low in both arrays at comparable levels. The signals 
of exons of housekeeping genes (open circles in red), how-
ever, are smaller by two orders of magnitude in the antisense 
array, indicating that antisense labeling does not mark sense 
transcripts. Signals are in log scale with base 2.
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Known antisense transcripts are detected with strong 
signals
The Affymetrix Exon array includes pre-designed probes
for some known antisense transcripts. We identified
24,750 pairs of probes that form sense-antisense pairs. We
first searched for all pairs of probes whose targeted
genomic region overlaps with each other, and then
selected those pairs that are on opposite DNA strands. As
shown in Fig. 2A, on the same array, these pairs have a
tendency toward negative correlation in their expression
(Pearson's correlation coefficient R = -0.18). The "L"-
shaped scatter plot indicates co-expression of many of
these pairs, but high expression (log2 signal > 6) of both
strands is not observed. Between the sense and antisense
arrays (Fig. 2B), these pairs showed a strong positive cor-
relation (R = 0.72). This is expected since the same tran-
script is detected by a probe in the sense array and by an
adjacent probe on the opposite strand in the antisense
array. This strong positive correlation serves as a positive
control for our approach.
On the level of individual genes, many known NATs were
detected by our ATE method. For example, Fig. 3 gives the
expression levels of all the exons of the solute carrier fam-
ily 3, member 1 (SLC3A1) gene. The sense array suggests
a very low level of expression across all exons. Examina-
tion of detection P values indicates that that expression of
all these exons is too low to be detectable via microarray
analysis. In other words, the signals are indistinguishable
from the background defined by a set of negative control
probes matched by GC content. The antisense array, how-
ever, detected strong signals in the two probes represent-
ing the last exon. This could suggest the expression of
NATs on this exon.
Also notice that for exons No.1 to No. 9, the signals of
sense and antisense arrays are approximately equal for the
same probe, despite the fact that they are detecting tran-
scripts on different strands. The correlated signals indicate
probe-dependent non-specific signal. Compared with
these nine probes, the 10-fold increase of exon 10 in the
antisense strand is remarkable.
The SLC3A1 gene is known to form sense-antisense pair
with another well-annotated gene prolyl endopeptidase-
like (PREPL) [3,4]. These two genes overlap on their last
exons and are transcribed from different DNA strands
(Fig. 4A). The PREPL gene is apparently highly expressed
in Jurkat cell, because most exons of this gene are detected
with high signals (Fig. 4B). The strong signal (Fig. 4C)
picked up by the antisense array at the last exon of the
SLC3A1 gene thus must come from its antisense genes,
PREPL. Therefore, the antisense transcript of SLC3A1 is
successfully detected. Also note that the exons of the
PREPL gene were not detected by the antisense array. This
reassured us again of the strand-specificity of our method.
Our ATE method also detected many other similar pairs
such as {NIT1,  DEDD} pair on Chr. 1q21, {ADCY3,
CENPO} pair on Chr. 2p24, etc. Although we are more
interested in cases in which the antisense transcript is not
well annotated, detection of known antisense transcripts
serve as a strong confirmation of our ATE protocol.
Expression of sense-antisense probe pairs Figure 2
Expression of sense-antisense probe pairs. Each point represents a pair of probes, A and B, which target different strands 
of the same genomic loci. Shown in the left (a) are the expression levels of probe A and B in the same (sense) array. The right 
figure (b) gives the expression level of probe A in sense array (x-axis) versus that of probe B in the antisense array (y-axis). Sig-
nals are in log scale with a base of 2.BMC Genomics 2008, 9:27 http://www.biomedcentral.com/1471-2164/9/27
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Thousands of antisense transcripts are detected
To determine the number of antisense transcripts confi-
dently detected in Jurkat cells by our ATE approach, we
performed a series of filtering procedures. First of all, we
focused on exons supported by full-length mRNAs like
RefSeq. This reduced the number of probes from over 1
million to 289,961. Probes that are represented by less
than 3 features or probes that could cross-hybridize to
other transcripts were also eliminated. The remaining
184,163 high-quality probes will be analyzed in both
sense and antisense strands.
To define genes confidently detected by antisense array,
we first required that the signal to be higher than those of
the 942 negative control probes on the same array. Back-
ground levels are indeed probe-specific, but most varia-
tions can be contained within a certain range and an
absolute cutoff value is still useful. A threshold of log2-
based score of 4.34 was chosen as only 29 (3.0%) of these
probes are above this level. Also the detection P value
should be smaller than 0.01. To further eliminate non-
specific signals, the signal produced by a probe in the anti-
sense array must be higher than the signals produced by
the same probe in most of the 73 Exon arrays. Since
Affymetrix exon arrays do not include mis-match probes
that serve as probe-level controls, we found defining a
probe-specific background signal by the distribution of
signals in a large number of hybridizations very impor-
tant. For each probe we calculated the mean and standard
deviation of the signals observed in the 73 samples, which
were used to compute a Z score to represent the observed
signal in antisense or sense array. We used a conservative
threshold of a Z score larger than 1, which is approxi-
mately equal to the requirement that the observed signal
should be larger than 62 (86%) of 73 samples in the
Affymetrix dataset.
Using these criteria, we determined the number of
expressed probes in both arrays. As shown in Table 1, the
number of probes detected by the antisense array (2,282)
is much smaller than that detected by the sense array
(39,373). The 2,282 probes detected by the antisense
array represent 2,088 exons of 1,516 UniGene clusters.
These probes and expression data are available in addi-
tional file 1. Hence, antisense transcripts targeting 1,516
well-annotated genes were detected by our method. A rel-
atively large proportion (38.5%) of the exons targeted by
antisense transcripts represents untranslated regions
(UTRs). Among 1,516 genes, 490 (31.6%) have been
reported by Chen et al. [4] or Yelin et al. [3] that were
involved in antisense transcription. In other words, we
identified 1,026 potentially novel antisense transcripts
that were not detected by studies based on public data-
bases of expressed sequences. If the 4,070 unique pairs
reported by Chen et al. [4] or Yelin et al. [3] are considered
the set of known antisense transcrits, we detected the
expression 12% (490 out of 4,070) of them in Jurkat cells.
Using orientation-specific RT-PCR we performed valida-
tion of 24 of the identified NATs (see Fig. 5) according to
the protocol of Chen et al. [4]. One known sense-antisense
pair corresponding to two genes (ADCY3 and CENPO)
with overlapping 3' UTR was included and was confi-
dently detected. The negative control was performed by
reverse transcription in absence of primers followed by
PCR amplification. No signal was detected across all 24
cases, which excludes genomic DNA contamination and
primer independent cDNA synthesis [18]. Strong bands
suggest that 17 (74%) of 23 identified novel antisense
transcripts, in agreement with our antisense microarray
results.
Since Affymetrix Exon array includes probes interrogating
both strands of some genomic loci, it is also possible to
detect some antisense transcripts based on data from the
sense array alone. Applying the above-mentioned criteria
to pairs of overlapping probes on both strands, we
detected antisense transcripts targeting 649 genes. Over
half (52.5%) of these genes have been reported to form
sense-antisense pairs in refs. [3] or [4]. Therefore, detec-
tion of antisense transcripts using these probes is limited
by available annotation, whereas our new method can
potentially detect antisense transcripts on all exons across
the human genome.
Discussion
Our method is clearly limited to NATs at known or pre-
dicted exonic loci. A more comprehensive survey would
The expression levels of the 10 exons of the SLC3A1 gene  on Chr Figure 3
The expression levels of the 10 exons of the SLC3A1 
gene on Chr.2p21. The expression levels of the exons are 
very low as measured by the sense array processed accord-
ing to standard protocol. A strong signal is detected by the 
antisense array on the last exon, indicating transcription from 
this exon on the opposite strand.
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use genomic tiling arrays in a strand-specific fashion. Cur-
rently, the Affymetrix Human Tiling 2.0R array set uses
seven chips to interrogate the non-repetitive regions of the
whole genome at a 35 base pair resolution. Thus the cost
of tiling array is much higher and use of tiling arrays for
routine measurements of NAT expression in a large
number of samples is difficult. Exon array provides a good
balance between cost and coverage, as it targets most tran-
scriptionally active loci at an affordable price.
The elimination of the RNA amplification process neces-
sitates a large amount of total RNA. This is clearly a limi-
tation of the ATE method. Our antisense array
hybridization used about ~80 μg of total RNA. This does
not translate into a huge amount of tissues. Even for the
Table 1: Detected exons in Jurkat cells in sense and antisense arrays.
Probes Exons Transcript Clusters UniGene Clusters
Total on array 1,384,231 1,084,639
Highly specific probes for known genes 184,163 143,243 17,605 16,332
Expressed in Jurkat cell (sense array) 39,373 33,639 6,469 6,205
Expressed in Jurkat cell (antisense array) 2,282 2,088 1,718 1,516
Expressed in both arrays (% of antisense) 392 (17%) 430 (21%) 652(38%) 585(39%)
Expression data for a gene with a known antisense transcript Figure 4
Expression data for a gene with a known antisense transcript. (A) The 3' ends of SLC3A1 and PREPL genes overlap on 
their last exons. (B) On the sense array, exons of PREPL gene are highly expressed while all exons of the SLC3A1 gene are 
extremely low. (C) Processed according to our ATE protocol, the antisense array only detects higher levels of expression of 
the last exon of the SLC3A1 gene.
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RNA-poor tissues like muscle and lung, this only requires
no more than 80 mg of tissue. RNA yields for other com-
mon tissues are often 2 to 5 times higher [19]. Therefore,
in addition to cell lines and normal tissues, ATE method
should be applicable to many clinical studies for simulta-
neous monitoring of transcriptions at both sense and antisense
orientation. In addition to human exon array, Affymetrix
also provides similar Exon arrays for mouse and rat. In
these model animals RNA is often available in large quan-
tities, and the ATE method could be valuable for large-
scale study of antisense expression.
Conclusion
We demonstrated that high-throughput expression analy-
sis of antisense transcripts could be achieved by using
commercial DNA microarrays. By modifying the recom-
mended cDNA synthesis protocol, it is possible to label
targets in reverse orientation as what would be labeled
according to the standard protocol. Our microarray data
on human Jurkat cells showed that the modified protocol
can successfully detect a large number of NATs transcribed
from known exonic loci.
Methods
Materials
Total RNA (100 μg, Cat.#7858) of human Jurkat cells
(derived from T-cell leukemia) was purchased from
Ambion (Austin, TX). Ribosomal RNA (rRNA) reduction
was performed using the RiboMinus Kit from Invitrogen
(Carlsbad, CA). This sample was used for both sense and
antisense analyses.
Sense strand expression analysis using standard protocol
Sense strand expression profiling was performed accord-
ing to recommended protocol [16]. Briefly, double-
stranded cDNA is synthesized with random hexamers
coupled with a T7 promoter sequence. The cDNA is then
used as a template for in vitro transcription (IVT) amplifi-
cation with T7 RNA Polymerase, producing multiple cop-
ies of cRNAs that are reverse complementary to original
mRNA. In the second cycle cDNA synthesis, random
primers are used in reverse transcription to convert the
cRNA into single-stranded DNA in the same orientation as
original mRNAs. The single-stranded cDNA are then frag-
mented, labeled, and hybridized to the array. To ensure
hybridization, the probe sequences on the array are pre-
manufactured in the opposite orientation of mRNAs reg-
istered in annotation databases.
Antisense Transcriptome analysis using Exon (ATE) array
Compared with standard protocol, the ATE protocol skips
the first cycle cDNA synthesis and the IVT amplification
process, and starts directly from the second cycle cDNA
synthesis. The labeled target DNA fragments are in reverse
orientation of original mRNAs. Thus hybridization signals
will represent transcripts from the same exonic regions
but from the opposite DNA strand.
Briefly, the ATE protocol involves the following steps:
1. Removal of ribosomal RNA from total RNA using the
RiboMinus Kit.
2. 1st strand cDNA synthesis using random primers. dUTP
is incorporated in the DNA during reverse transcription.
3. Cleanup of RNA using RNase H.
4. The single-stranded DNA sample is treated by a combi-
nation of uracil DNA glycosylase (UDG) and apurinic/
apyrimidinic endonuclease 1 (APE 1) that specifically rec-
ognizes the dUTP residues and breaks the DNA into frag-
ments.
5. Fragmented single-stranded DNA is labeled with
recombinant terminal deoxynucleotidyl transferase (TdT)
and the Affymetrix DNA Labeling Reagent. The reagent is
covalently linked to biotin.
6. Hybridization and scanning.
The ATE protocol is a straightforward method for measur-
ing antisense transcription without involving double-
strand DNA. For details on each of the above steps, see
[16].
Validation of antisense transcripts by orientation-specific  reverse transcription (RT) PCR Figure 5
Validation of antisense transcripts by orientation-
specific reverse transcription (RT) PCR. A total of 23 
novel antisense transcripts detected by microarray were 
included. In addition, one known sense-antisense pair (ADCY3 
and CENPO), which is marked as "C", was included as a posi-
tive control. For each genomic locus, three RT reactions 
were performed: (a) RT with reverse primer, targeting sense 
transcript (b) RT with forward primer, targeting antisense 
transcript, and (c) RT without primer, as negative control. 
Bolded primer IDs indicate bands that were considered sig-
nificant in antisense transcription.
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Validation of antisense transcripts using strand-specific 
RT-PCR
Total RNA from Jurkat cell (Ambion, TX) was used as tem-
plate, which was pre-treated with DNase I to remove
potential genomic DNA contamination. Twenty four Pairs
of PCR primers were designed using Primer3 software [20]
to target 100–200 bp regions at 24 exonic loci that were
found to have antisense transcription by our antisense
array (see additional file 2 for the primers). We used a
Qiagen One Step RT-PCR kit following a procedure simi-
lar to the one used by Chen et al. [4]. The strand-specificity
of the Qiagen kit for studying antisense transcription is
also confirmed by Haddad et al [18].
The experimental confirmation for each of the 24 NATs
involves a reverse transcription (RT) step followed by a
PCR reaction. Orientation of transcript was assessed by
selective use of primers during single-strand cDNA synthe-
sis in the RT step. To detect the sense transcripts, the
reverse primer was used for RT; to detect the antisense
transcript, the forward primer was used for RT. In addi-
tion, a negative control against genomic contamination
was carried out by performing RT without any primer in
RT. Therefore, three separate reactions were performed for
each targeted NAT. All of these RT processes were followed
by PCR reactions under identical conditions with the pres-
ence of both forward and reverse primers. PCR products
were visualized on 2% agarose gels. The cycling parame-
ters were: (1) 50°C × 30 m, reverse transcription for sin-
gle-strand cDNA synthesis; (2) 95°C × 15 m, activate
AmpliTaq polymerase, inactivate RT enzymes; (3) 4°C,
add missing primers for PCR; (4) 94°C × 30s, commence
PCR cycling; (5) 60°C × 30s; (6) 72°C × 60s; (7) go to
step (4) and repeat 35 cycles in total; and (9) 72°C × 10
m. These cycling parameters are the same as those used by
Chen et al. [4], except step (6) which was changed to 72°C
× 60 s instead of 72°C × 35s.
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